We are live on ! Find out more
RG

Redmile Group Portfolio holdings

AUM $1.51B
1-Year Est. Return 164.17%
This Fund
S&P 500
This Quarter Est. Return
+4.96%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$1.51B
AUM Growth
+$152M
Cap. Flow
+$148M
Cap. Flow %
9.78%
Top 10 Hldgs %
81.92%
Holding
39
New
5
Increased
6
Reduced
16
Closed
4

Top Buys

1
SRRK icon
Scholar Rock
SRRK
+$172M
2
ANNX icon
Annexon
ANNX
+$25.3M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$10.1M
4
ALXO icon
ALX Oncology
ALXO
+$8.95M
5
PRME icon
Prime Medicine
PRME
+$6.05M

Top Sells

1
RAPT
RAPT Therapeutics
RAPT
+$30M
2
COGT icon
Cogent Biosciences
COGT
+$27.7M
3
REPL icon
Replimune Group
REPL
+$10.7M
4
IDYA icon
IDEAYA Biosciences
IDYA
+$7.41M
5
NRIX icon
Nurix Therapeutics
NRIX
+$5.99M

Sector Composition

1 Healthcare 100%

No holdings matched the selected filter criteria.

1 2

Similar funds

ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
HCMG
Howard Capital Management Group Los Angeles, California $1.51B AUM 21.57% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.51B AUM 25.86% 1-Year Est. Return
FCM
Fairholme Capital Management South Miami, Florida $1.51B AUM 28.27% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.52B AUM 18.08% 1-Year Est. Return
AM
Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.5B AUM 11.68% 1-Year Est. Return